Implementing act · EU
Commission Regulation (EU) No 823/2012 of 14 September 2012 derogating from Implementing Regulation (EU) No 540/2011 as regards the expiry dates of the approval of the active substances 2,4-DB, benzoic acid, beta-cyfluthrin, carfentrazone ethyl, Coniothyrium minitans Strain CON/M/91-08 (DSM 9660), cyazofamid, cyfluthrin, deltamethrin, dimethenamid-P, ethofumesate, ethoxysulfuron, fenamidone, flazasulfuron, flufenacet, flurtamone, foramsulfuron, fosthiazate, imazamox, iodosulfuron, iprodione, isoxaflutole, linuron, maleic hydrazide, mecoprop, mecoprop-P, mesosulfuron, mesotrione, oxadiargyl, oxasulfuron, pendimethalin, picoxystrobin, propiconazole, propineb, propoxycarbazone, propyzamide, pyraclostrobin, silthiofam, trifloxystrobin, warfarin and zoxamide Text with EEA relevance
- Identifier
- CELEX 32012R0823
- Status
- in_force
- Adopted
- 14 September 2012
- Published
- 14 September 2012
- Language
- en
- Official source
- https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32012R0823
- Source provider
- eurlex
- Retrieved
- 2026-08-27T22:58:34.775Z
Identifier
- CELEX: 32012R0823 · eurlex
Direct relationships
PoliticalRepo: CELEX 32012R0823
- Identifier matchPROJECTS_FROM
Same CELEX 32012R0823 projected from PoliticalRepo EUR-Lex row 32012R0823.
LegalInstrument → PoliticalRecord · Open related record